Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epigenetic events in medulloblastoma development.

Janet C Lindsey1, Jennifer A Anderton, Meryl E Lusher

  • 1Northern Institute for Cancer Research, University of Newcastle, Newcastle upon Tyne, United Kingdom.

Neurosurgical Focus
|January 10, 2006
PubMed
Summary

Epigenetic changes, specifically promoter hypermethylation, inactivate tumor suppressor genes in medulloblastoma, a common childhood brain tumor. This offers new insights into medulloblastoma development and potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

EClinicalMedicine·2026
Same author

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

The Lancet. Child & adolescent health·2026
Same author

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Neuro-oncology·2026
Same author

Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing.

Acta neuropathologica communications·2025
Same author

Salvage therapies for first relapse of SHH medulloblastoma in early childhood.

Neuro-oncology·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor.
  • Understanding the molecular basis of medulloblastoma pathogenesis remains incomplete.
  • Epigenetics, heritable gene expression changes without DNA alteration, is increasingly recognized in cancer.

Purpose of the Study:

  • To review the current understanding of epigenetic events in medulloblastoma.
  • To explore the role of epigenetic alterations in medulloblastoma development.
  • To assess the potential of epigenetic events for novel diagnostic and therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on epigenetics and medulloblastoma.
  • Analysis of studies identifying epigenetically silenced tumor suppressor genes.

Related Experiment Videos

  • Consideration of the nature, origins, and functional roles of epigenetic events.

    • Main Results:

    • Epigenetic events, particularly promoter hypermethylation, significantly contribute to medulloblastoma development.
    • Candidate tumor suppressor genes (e.g., RASSF1A, CASP8, HIC1) are epigenetically inactivated in over 30% of medulloblastomas.
    • Gene silencing due to hypermethylation is a key mechanism of disruption.

    Conclusions:

    • Epigenetic inactivation of tumor suppressor genes provides new insights into medulloblastoma pathology.
    • Epigenetic alterations represent promising targets for future diagnostic and therapeutic interventions in medulloblastoma.